Metastatic Hormone Refractory Prostate Cancer Recruiting Phase 4 Trials for Enzalutamide (DB08899)

Also known as: Metastatic hormone refractory Prostate cancer / Metastatic Prostate cancer / Prostate cancer metastatic / Metastatic Prostate Carcinoma / Carcinoma of the prostate metastatic / Prostatic cancer metastatic

IndicationStatusPhase
DBCOND0036371 (Metastatic Hormone Refractory Prostate Cancer)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03016741Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate CancerSupportive Care